On September 19, 2023, Truist Securities analyst Richard Newitter expressed his continued optimism for Lantheus Holdings (NASDAQ:LNTH) by reiterating his Buy rating and maintaining a price target of $125. This reaffirmation of Truist Securities’ positive stance on the stock follows their earlier Strong Buy rating and a price target of $115. The most recent report from Truist Securities, released on September 15, 2023, further solidifies their confidence in Lantheus Holdings.
Lantheus Holdings, Inc.
LNTH
Buy
Updated on: 19/09/2023
Financial Health
Healthy
Debt to equity ratio: Buy
Price to earnings ratio: Strong Sell
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Sell
Lantheus Holdings, Inc. Stock Performance and Growth Analysis: September 19, 2023
On September 19, 2023, Lantheus Holdings, Inc. (LNTH) had a mixed performance in the stock market. The stock opened at $63.95 and traded within a range of $62.77 to $64.17. The trading volume was relatively low, with 19,365 shares traded. Lantheus Holdings, Inc. is a health technology company in the medical specialties industry with a market capitalization of $4.4 billion. The company has shown strong earnings and revenue growth, with a growth rate of +32.21% for this year and a growth rate of +119.91% in the last year. However, the stock has a relatively high P/E ratio of 130.4 and a price/sales ratio of 3.85. On the same day, Neogen Corp fell by 0.01 (-0.02%) and QuidelOrtho Corp dropped by 0.74 (-1.04%), but QuidelOrtho Corp managed to recover some of its losses. Lantheus Holdings, Inc. is scheduled to report its next earnings on November 2, 2023, with analysts forecasting an EPS of $1.37 for this quarter.
Lantheus Holdings Inc Receives Positive Forecasts and Ratings, Contributing to Strong Performance on September 19, 2023
LNTH stock had a favorable performance on September 19, 2023, as the company received positive forecasts and ratings from analysts. According to CNN Money, Lantheus Holdings Inc had 8 analysts offering 12-month price forecasts, with a median target of $125.00. The consensus among the analysts was to buy stock in Lantheus Holdings Inc, indicating a consistent positive sentiment towards the company’s future performance. The company also reported strong financials for the current quarter, with earnings per share of $1.37 and sales of $316.9 million. These positive forecasts, ratings, and financial results likely contributed to the stock’s performance on September 19, 2023. Investors may continue to monitor the company’s future developments and financial results for informed investment decisions.
Discussion about this post